Page results
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
Information about medications, vaccinations and travel for people with sickle cell disorder.
-
A summary of a twitter chat hosted by the Macmillan Support and Information Service on cancer-related fatigue with advice about to manage it.
-
This page provides information about different medicines that might help to relieve neuropathic pain.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
-
Information on parvovirus for patients with haemolytic anaemias.
-
This information explains radium-223 therapy treat available at University College Hospital.
-
This page provides information about an interventional procedure called an Epidural Fibrin Patch. It is intended for use by patients (or their family or carers), who have been referred to the NHNN.
-
This page explains more about the Prostate One-Day Clinic and what you can expect when you come for your appointment. If you have any questions about your appointment or the information included on this page, please contact one of our prostate clinical nurse specialists (CNSs).
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
File results
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0172 - Contraceptive pill data
-
FOI/2022/0174 - Clinical systems for bed management, diagnostic reporting, discharge letters, and integration platform systems
-
FOI/2022/0177 - Assessment and treatment unit for mental health and learning disabilities
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer